Decreasing voriconazole requirement in a patient after extracorporeal membrane oxygenation discontinuation: A case report

Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients

(2018) Vesa Cheng et al.   Expert Opinion on Drug Metabolism & Toxicology

Longitudinal Analysis of the Effect of Inflammation on Voriconazole Trough Concentrations

(2016) M. A. Encalada Ventura et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The effect of pathophysiology on pharmacokinetics in the critically ill patient — Concepts appraised by the example of antimicrobial agents

(2014) Stijn I. Blot et al.   ADVANCED DRUG DELIVERY REVIEWS

Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology

(2013) H. R. Ashbee et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Introduction to Drug Pharmacokinetics in the Critically III Patient

(2012) Brian S. Smith et al.   CHEST

ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO

(2012) Kiran Shekar et al.   BMC Anesthesiology

Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation

(2009) I. Spriet et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation

(2008) Stéphanie Ruiz et al.   INTENSIVE CARE MEDICINE